;Viability of a Drug-Resistant Human Immunodeficiency Virus Type 1 Protease Variant:
Structural Insights for Better Antiviral Therapy
;
J.VIROL. (2003)
Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes
Structure (2002)
Lack of synergy for inhibitors targeting a multi-drug resistant HIV-1 protease
Protein Sci. (2002)
How does a symmetric dimer recognize an asymmetric substrate? a substrate complex of HIV-1 protease
J.Mol.Biol. (2000)
ABT-538 Is a Potent Inhibitor of Human Immunodeficiency Virus Protease and has High Oral Bioavailability in Humans
Proc.Natl.Acad.Sci.USA (1995)